Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

GSK launches prostate drug

October 31, 2003 Sales and Marketing

GlaxoSmithKline is to launch Avodart, a new treatment for enlarged prostates, next week into a crowded $1.6 billion global market.The …
News

GSK in running for Pfizer incontinence drug

October 31, 2003 Sales and Marketing

GlaxoSmithKline has been tipped to buy a potential blockbuster incontinence drug from Pfizer ahead of the US company's merger with …
News

Look closer – The importance of local opinion leaders

October 29, 2003 Sales and Marketing key opinion leaders

There is no doubt that key opinion leader (KOL) development has always been a crucial component of the marketing mix; …
Feature

Limited lifting of NICE ‘ban’ on Tamiflu

October 29, 2003 Sales and Marketing

Roche have won a limited recommendation for its flu drug Tamiflu following a second NICE approval.An appraisal of flu drugs …
News

Betaferon and Avonex in head-to-head MS trial

October 29, 2003 Research and Development, Sales and Marketing

Schering AG is to launch the largest ever therapeutic multiple sclerosis trial, comparing its drug Betaferon with Biogen's rival Avonex.The …
News

AstraZeneca accused of blocking Losec competition

October 29, 2003 Sales and Marketing

News

Do doctors really use the Internet?

October 29, 2003 Sales and Marketing doctors, internet

Ever since the medical and pharmaceutical web emerged in the mid-90s, technology advocates have assumed that widespread use of the …
Feature

Celltech takes 10% stake in OGS

October 29, 2003 Sales and Marketing

News

Zyprexa approved for bipolar disorder

October 29, 2003 Sales and Marketing

Eli Lilly's market-leading schizophrenia drug Zyprexa has been granted European approval for the long-term treatment of bipolar disorder.The approval makes …
News

Shire cuts back ahead of US expansion

October 29, 2003 Sales and Marketing

Shire Pharmaceuticals is to revert to its original business model of marketing and developing specialist drugs in late stage clinical …
News

Pfizer/Pharmacia mega-merger gains final clearance

October 29, 2003 Sales and Marketing

The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …
News

AstraZeneca prepares Crestor for battle

October 29, 2003 Sales and Marketing

AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …
News

Yamanouchi reinforces US future with GSK deal

October 29, 2003 Sales and Marketing

Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US. …
News

Exanta on NICE list ahead of marketing authorisation

October 29, 2003 Sales and Marketing

AstraZeneca's Exanta is to be in NICE's next programme of appraisals even though the blood-thinning drug has not yet received …
News

Aventis sues generic rivals over Lovenox

October 29, 2003 Sales and Marketing

Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, …
News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026